Active ingredient

DEVICE5 trials

Sponsors

University of Notre Dame, Clinical Research Centre, Malaysia

Conditions

MalariaPneumonia

Phase 2

Effect of High Dose Intravenous Vitamin C in Severe Pneumonia

RecruitingNCT05842382

Clinical Research Centre, MalaysiaPneumonia

Start: 2024-01-12End: 2026-02-28Target: 484Updated: 2024-06-20

Unknown Phase

Spatial Repellent Products for the Control of Vector Borne Diseases - Malaria - Kenya

WithdrawnNCT02294201

University of Notre DameMalaria

Start: 2016-06-30End: 2016-07-31Updated: 2016-10-06

Spatial Repellent Products for the Control of Vector Borne Diseases - Malaria - Tanzania

WithdrawnNCT02294214

University of Notre DameMalaria

Start: 2016-02-29End: 2016-04-30Updated: 2016-10-06

Spatial Repellent Products for Control of Vector Borne Diseases - Malaria - Indonesia

CompletedNCT02294188

University of Notre DameMalaria

Start: 2015-05-31End: 2018-04-15Updated: 2018-05-03

Spatial Repellent Products for Control of Vector Borne Diseases - Malaria - Zambia (SR-M-ZM)

WithdrawnNCT02394522

University of Notre DameMalaria

Start: 2016-03-31End: 2016-04-30Updated: 2016-10-06